1805189-72-3Relevant articles and documents
ISOQUINOLINONE DERIVATIVES AS PARP INHIBITORS
-
Page/Page column 48, (2017/02/09)
Disclosed are compounds of formula (I), their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts thereof, wherein R1-R6, R1a, R2a, R1b, R2b, R1c, R2c, p and q are as defined in the specification, pharmaceutical compositions including a compound, tautomer, stereoisomer, or salt thereof, and methods of treating or preventing diseases or disorders, for example, cancer, that are amenable to treatment or prevention by inhibiting the PARP enzyme of a subject.